Ohio Holdings Corp. (NASDAQ: PKOH) today announced its results for the fourth quarter and full year 2025.
Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026; Type A meeting with FDA expected to occur within 30 daysOn track to submit regulatory applications for ...
Industry participation is also expanding through the involvement of NEURA Robotics as the incubator’s first corporate sponsor. David Reger, founder and Chief Executive Officer of NEURA Robotics, said ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果